
[摘要] 目的 探討硫酸鎂聯合硝苯地平治療妊高癥的治療效果及安全性。方法 方便選取2011年10月—2015年10月入住該院的82例妊高癥患者按照治療方法隨機分為對照組(n=40)與觀察組(n=42),兩組均首先給予解痙、降壓、抗痙攣以及補充血容量等治療,對照組在此基礎上給予硫酸鎂注射液靜滴,觀察組在對照組治療基礎上聯合硝苯地平治療。比較兩組療效。結果 ①兩組患者治療后血壓、24 h尿蛋白定量水平均顯著低于治療前,差異有統計學意義(P<0.05);②兩組患者治療后血漿黏度水平較治療前均顯著下降,差異有統計學意義(P<0.05);③對照組不良反應發生率為17.50%(7/40),顯著低于觀察組(9.52%,4/42),差異有統計學意義(P<0.05)。結論 硫酸鎂聯合硝苯地平在妊娠高血壓治療過程中的療效顯著,安全性較高,應加以推廣。
[關鍵詞] 妊娠高血壓;硝苯地平;硫酸鎂;療效;安全性
[中圖分類號] R5 [文獻標識碼] A [文章編號] 1674-0742(2016)11(a)-0105-03
[Abstract] Objective To investigate the magnesium sulfate and nifedipine RenGaoZheng therapeutic effect and safety. Methods Convenient selection 82 patients with pregnancy-induced hypertension patients in our hospital from October 2011 to October 2015 were randomly divided into treatment in accordance with the control group(n=40) and the observation group(n=42), two groups were first given antispasmodic, antihypertensive, anti-spasmodic and additional blood volume and other treatment, the control group received magnesium sulfate on the basis of intravenous injection, combined with the observation group in the control group treated with nifedipine treatment basis. Comparison of the two groups. Results ①After treatment blood pressure, 24h urinary protein excretion was significantly lower than before treatment (P <0.05); ②The two groups of patients before treatment, plasma viscosity level than before treatment were significantly decreased (P <0.05);③In the control group reactions was 17.50% (7/40), significantly lower than the observation group (9.52%, 4/42) (P <0.05). Conclusion The effect of magnesium sulfate and nifedipine in the treatment of hypertension during pregnancy was significantly higher security and should be promoted.
[Key words] Pregnancy induced hypertension; Nifedipine; Magnesium sulfate; Efficacy; Safety
妊娠高血壓疾病,又稱“妊高癥”,嚴重威脅著產婦及胎兒的生命健康,是導致孕產婦死亡的重要原因之一[1]。目前,臨床上常使用硫酸鎂溶液對妊高癥患者進行治療,但是其起效時間較長,對于病情較為嚴重的患者在較短時間內難以達到明顯的降壓效果。臨床上一般多采取硫酸鎂注射液對妊高癥患者進行治療,然而其對于降低蛋白尿含量、降低患者血壓水平以及緩解患者水腫程度等的療效均不夠理想。于是該研究主要將硫酸鎂聯合硝苯地平用于2011年10月—2015年10月入住該院的82例妊娠高血壓患者的臨床治療之中,效果顯著,現報道如下?!?br>